Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	515	459	504	3,382	3,197	13,391
Market Cap Growth	36.52%	-9.05%	-85.09%	5.78%	-76.12%	-
Enterprise Value	541.55	453.23	381.61	2,660	2,295	11,925
Last Close Price	7.89	8.31	9.82	67.60	67.60	332.40
PS Ratio	3.33	2.70	2.22	13.45	6.69	42.67
PB Ratio	1.07	0.90	0.70	3.08	1.84	8.90
P/TBV Ratio	1.01	0.91	0.71	3.00	1.64	7.51
EV/Sales Ratio	3.58	2.66	1.68	10.58	4.80	38.00
Debt / Equity Ratio	0.93	0.82	0.61	0.20	0.24	0.01
Net Debt / Equity Ratio	0.08	-0.01	-0.17	-0.66	-0.52	-1.01
Net Debt / EBITDA Ratio	-0.15	0.02	0.25	0.91	0.42	0.85
Net Debt / FCF Ratio	-0.22	0.03	0.32	2.15	2.96	4.92
Asset Turnover	0.11	0.14	0.15	0.12	0.21	0.23
Inventory Turnover	-	-	-	-	121.49	42.54
Quick Ratio	4.95	4.66	5.44	5.87	8.08	12.51
Current Ratio	5.15	4.92	5.62	6.11	8.38	12.79
Return on Equity (ROE)	-79.95%	-51.08%	-60.34%	-63.02%	-127.52%	-180.29%
Return on Assets (ROA)	-27.56%	-25.18%	-36.76%	-41.11%	-95.15%	-133.06%
Return on Invested Capital (ROIC)	-48.84%	-46.36%	-83.58%	-101.67%	-289.00%	-545.85%
Return on Capital Employed (ROCE)	-30.11%	-27.49%	-40.39%	-44.70%	-102.68%	-144.08%
Buyback Yield / Dilution	-7.29%	-6.87%	-6.76%	-15.75%	-23.48%	-6.72%
Total Shareholder Return	-7.29%	-6.87%	-6.76%	-15.75%	-23.48%	-6.72%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q